Cantor Fitzgerald analyst Brian Cheng reiterated an Overweight rating on Gossamer Bio Inc. (NASDAQ: GOSS).The analyst commented, "We've heard all ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE